SEC Form 4 · accession 0001104659-18-022242

Ophthotech Corp. · OPHT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — President and CEO

Period of report

Apr 1, 2018

Accepted (ET)

Apr 3, 2018 · 7:06 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001410939

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Apr 1, 2018	M	18,750	—	A	55,245	D
Common Stock^F2,F3	Apr 2, 2018	S	6,838	$2.69	D	48,407	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Units^F1,F4	—	Apr 1, 2018	M	18,750	D	—	Mar 31, 2026	Common Stock	18,750	37,500	D

F1Restricted stock units converted into common stock on a one-for-one basis upon vesting of the units.
F2Represents shares automatically sold pursuant to the pre-specified terms of the applicable Restricted Stock Unit Agreement to satisfy the reporting person's minimum statutory withholding obligations with respect to the income recognized by the reporting person upon the vesting of the restricted stock units on April 1, 2018.
F3These shares were disposed of in multiple transactions on April 2, 2018 at actual sales prices ranging from $2.67 to $2.71 per share. The price reported reflects the weighted average sale price for the transactions. The reporting person undertakes to provide upon request by the staff of the Securities Exchange Commission, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4On April 1, 2016, the reporting person was granted an award of 75,000 restricted stock units, which vests with respect to 25% of the shares subject to the award on each of the first, second, third and fourth anniversaries of the grant date, subject to continued employment with the issuer and the other terms and conditions under the issuer's 2013 Stock Incentive Plan